JLK, Inc. (KOSDAQ:322510)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,890.00
-460.00 (-6.26%)
Mar 9, 2026, 3:30 PM KST

JLK, Inc. Company Description

JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea.

The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases.

The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer’s disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology.

JLK, Inc. was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. was incorporated in 2014 and is based in Cheongju-si, South Korea.

JLK, Inc.
Country South Korea
Founded 2014
Industry Conglomerates
Sector Industrials
CEO Dongmin Kim

Contact Details

Address:
#204, 10, Yangcheongsongdae-gil
Cheongju-si
South Korea
Phone 82 7 04651 4051
Website jlkgroup.com

Stock Details

Ticker Symbol 322510
Exchange KOSDAQ
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7322510009
SIC Code 7372

Key Executives

Name Position
Dongmin Kim Chief Executive Officer